标题
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias
作者
关键词
-
出版物
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume -, Issue -, Pages jnnp-2021-326603
出版商
BMJ
发表日期
2021-06-09
DOI
10.1136/jnnp-2021-326603
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
- (2021) Nicholas J. Ashton et al. ACTA NEUROPATHOLOGICA
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
- (2020) Nicolas R. Barthélemy et al. Alzheimers Research & Therapy
- Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
- (2020) Juan Lantero Rodriguez et al. ACTA NEUROPATHOLOGICA
- Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
- (2020) Juan Fortea et al. LANCET
- Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases
- (2020) Giovanni Palermo et al. MOLECULAR NEUROBIOLOGY
- Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
- (2020) C. Delaby et al. Scientific Reports
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
- (2020) Shorena Janelidze et al. JAMA Neurology
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer’s disease
- (2019) Estrella Morenas-Rodríguez et al. Scientific Reports
- Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood
- (2019) Robert Hendricks et al. Bioanalysis
- Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
- (2019) Daniel Alcolea et al. Annals of Clinical and Translational Neurology
- Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer’s disease: Where do we stand?
- (2019) Bhavana Veerabhadrappa et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A Multicenter Study in Spain
- (2018) Daniel Alcolea et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
- (2018) Juan Fortea et al. LANCET NEUROLOGY
- Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform
- (2018) Constance Delaby et al. CLINICA CHIMICA ACTA
- An UHPLC–MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction
- (2017) Ping-ping Lin et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Quantitative immunocapture MS: current status and challenges in drug discovery
- (2014) John Kellie et al. Bioanalysis
- Impact of harmonization of collection tubes on Alzheimer's disease diagnosis
- (2013) Sylvain Lehmann et al. Alzheimers & Dementia
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started